Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine

scientific article

Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID7907650

P2093author name stringC J Schmidt
C K Sullivan
G M Fadayel
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectdopamineQ170304
striatumQ1319792
P304page(s)1382-1389
P577publication date1994-04-01
P1433published inJournal of NeurochemistryQ6295643
P1476titleBlockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine
P478volume62

Reverse relations

cites work (P2860)
Q388291903,4-Methylenedioxymethamphetamine Increases Affiliative Behaviors in Squirrel Monkeys in a Serotonin 2A Receptor-Dependent Manner.
Q363343985-HT(2A) receptor blockade and 5-HT(2C) receptor activation interact to reduce cocaine hyperlocomotion and Fos protein expression in the caudate-putamen
Q449626195-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion
Q37012610Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons
Q42712127Blockade of 5-HT2A receptors in the medial prefrontal cortex attenuates reinstatement of cue-elicited cocaine-seeking behavior in rats
Q33819387Botulinum Neurotoxin A Injected Ipsilaterally or Contralaterally into the Striatum in the Rat 6-OHDA Model of Unilateral Parkinson's Disease Differently Affects Behavior
Q33187198Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats
Q42025447Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice
Q55066895Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotonin.
Q35107898Effects of MDMA on Extracellular Dopamine and Serotonin Levels in Mice Lacking Dopamine and/or Serotonin Transporters
Q40957166Effects of chronic neuroleptic treatment on dopamine release: insights from studies using 3-methoxytyramine
Q36038551Genotype-Dependent Difference in 5-HT2C Receptor-Induced Hypolocomotion: Comparison with 5-HT2A Receptor Functional Activity.
Q36800689Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain
Q37149027MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology
Q41232968Mechanisms of action of atypical antipsychotic drugs: a critical analysis
Q36966673Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET.
Q30493133Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission
Q36997751Pharmacological models of ADHD.
Q37800812Presynaptic control of serotonin on striatal dopamine function
Q33763197Reverse microdialysis of a 5-HT2A receptor antagonist alters extracellular glutamate levels in the striatum of the MPTP mouse model of Parkinson's disease
Q42008895Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration
Q34025177The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine
Q36825547[3H]MDL 100,907: a novel selective 5-HT2A receptor ligand

Search more.